Dual-functional transdermal drug delivery system with controllable drug loading based on thermosensitive poloxamer hydrogel for atopic dermatitis treatment

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Wenyi ^a   Wat, Elaine ^b   Hui, Patrick C L ^a   Chan, Ben ^b   Ng, Frency S F ^a   Kan, Chi Wai ^a   Wang, Xiaowen ^a   Hu, Huawen ^a   Wong, Eric C W ^b   Lau, Clara B S ^b   Leung, Ping Chung ^b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEL; POLOXAMER;

ADMINISTRATION AND DOSAGE; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DERMATITIS, ATOPIC; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RELEASE; FLOW KINETICS; HUMAN; HYDROGEL; PATHOLOGY; SKIN; TEMPERATURE;

ADMINISTRATION, CUTANEOUS; DERMATITIS, ATOPIC; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; HUMANS; HYDROGEL; POLOXAMER; RHEOLOGY; SKIN; TEMPERATURE;

EID: 84973326040     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24112     Document Type: Article

References (54)

1. Bieber, T. Mechanisms of disease: Atopic dermatitis. N Engl J Med 358, 1483-1494 (2008).
2. Cookson, W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4, 978-988 (2004).
3. Holgate, S. T. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 28, 248-251 (2007).
4. Licona-Limon, P., Kim, L. K., Palm, N. W. & Flavell, R. A. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 14, 536-542 (2013).
5. Sandilands, A., Sutherland, C., Irvine, A. D. & McLean, W. H. I. Filaggrin in the frontline: role in skin barrier function. J Cell Sci 122, 1285-1294 (2009).
6. Charman, C. R., Morris, A. D. & Williams, H. C. Topical corticosteroid phobia in patients with atopic eczema. Brit J Dermatol 142, 931-936 (2000).
7. Leung, D. Y. M. & Bieber, T. Atopic dermatitis. Lancet 361, 151-160 (2003).
8. Lee, S. J. et al. Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants. Sci Rep 4, 7408 (2014).
9. Boneberger, S., Rupec, R. A. & Ruzicka, T. Complementary therapy for atopic dermatitis and other allergic skin diseases: facts and controversies. Clin Dermatoly 28, 57-61 (2010).
10. Mainardi, T., Kapoor, S. & Bielory, L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immun 123, 283-294; quiz 295-286 (2009).
11. Ernst, E. The usage of complementary therapies by dermatological patients: a systematic review. Brit J Dermatol 142, 857-861 (2000).
12. Haug S. R. A. et al. In Biofunctional Textiles and the Skin. Curr Probl Dermatol. Vol. 33 (ed Elsner P. Hipler, U.-C.) Ch. 10, 144-151 (Karger, 2006).
13. Lopes, C., Silva, D., Delgado, L., Correia, O. & Moreira, A. Functional textiles for atopic dermatitis: a systematic review and metaanalysis. Pediatr Allergy Immunol 24, 603-613 (2013).
14. Hipler, U. C. & Wiegand, C. in Handbook of medical textiles Ch. 12, 280-294 (Woodhead Publishing Limited, 2011).
15. Elsner P., Hipler, U.-C. In Biofunctional Textiles and the Skin. Curr Probl Dermatol. Vol. 33 (ed Elsner P. Hipler, U.-C.) Ch. 11, 165-178 (Karger, 2006).
16. Dastjerdi, R. & Montazer, M. A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties. Colloid Surface B 79, 5-18 (2010).
17. A., G. In Biofunctional Textiles and the Skin. Curr Probl Dermatol. Vol. 33 (ed Elsner P., Hipler, U.-C.) 152-164 (Karger, 2006).
18. Driver, V. R. Silver dressings in clinical practice. Ostomy Wound Manage 50, 11s-15s (2004).
19. Gupta, M., Mahajan, V. K., Mehta, K. S. & Chauhan, P. S. Zinc therapy in dermatology: a review. Dermatol Res Pr 2014, 709152 (2014).
20. JTM, B. et al. Oral evening primrose oil and borage oil for eczema. Cochrane Db Syst Rev. 30, CD004416 (2013).
21. Kanehara, S., Ohtani, T., Uede, K. & Furukawa, F. Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: a double-blind, placebo-controlled clinical trial. J Dermatol 34, 811-815 (2007).
22. Ricci, G., P. A., Bellini, F. & Medri, M. In Biofunctional Textiles and the Skin. Curr Probl Dermatol. Vol. 33 (ed Elsner P. Hipler, U.-C.) Ch. 9, 127-143 (Karger, 2006).
23. Goodyear, H. M., S. K. & Harper, J. I. Wet-wrap dressings for the treatment of atopic eczema in children. Brit J Dermatol 125, 604 (1991).
24. Lee, J. H., Lee, S. J., Kim, D. & Bang, D. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. J Eur Acad Dermatol 21, 1360-1368 (2007).
25. Devillers, A. C. & Oranje, A. P. Wet-wrap treatment in children with atopic dermatitis: a practical guideline. Pediatr Dermatol 29, 24-27 (2012).
26. Dabade, T. S. et al. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J Am Acad Dermatol 67, 100-106 (2012).
27. Janmohamed, S. R. et al. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 70, 1076-1082 (2014).
28. Lin, C. C. & Metters, A. T. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliver Rev 58, 1379-1408 (2006).
29. Kim, S. et al. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 31, 4157-4166 (2010).
30. Bhattarai, N., Ramay, H. R., Gunn, J., Matsen, F. A. & Zhang, M. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J Control Release 103, 609-624 (2005).
31. Jeong, B., Kim, S. W. & Bae, Y. H. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliver Rev 64, 154-162 (2012).
32. Wu, Q. et al. Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeatedinjury model. Sci Rep 5, 13553 (2015).
33. Dumortier, G., Grossiord, J. L., Agnely, F. & Chaumeil, J. C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23, 2709-2728 (2006).
34. Trong, L. C., Djabourov, M. & Ponton, A. Mechanisms of micellization and rheology of PEO-PPO-PEO triblock copolymers with various architectures. J Colloid Interf Sci 328, 278-287 (2008).
35. Yuan, Y. et al. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int J Pharm 430, 114-119 (2012).
36. Desai, P. R., Jain, N. J., Sharma, R. K. & Bahadur, P. Effect of additives on the micellization of PEO/PPO/PEO block copolymer F127 in aqueous solution. Colloid Surface A 178, 57-69 (2001).
37. Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P. & Peppas, N. A. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15, 25-35 (1983).
38. Prausnitz, M. R., Mitragotri, S. & Langer, R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3, 115-124 (2004).
39. Prausnitz, M. R. & Langer, R. Transdermal drug delivery. Nat Biotechnol 26, 1261-1268 (2008).
40. Lee, J. S. et al. Thermosensitive hydrogel-containing polymersomes for controlled drug delivery. J Control Release 146, 400-408 (2010).
41. Lin, Z. et al. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J Control Release 174, 161-170 (2014).
42. Ma, J. et al. Design and evaluation of a monolithic drug-in-adhesive patch for testosterone based on styrene-isoprene-styrene block copolymer. J Pharm Sci 102, 2221-2234 (2013).
43. Hui, P. C.-L. et al. Preparation and characterization of chitosan/sodium alginate (CSA) microcapsule containing Cortex Moutan. Colloid Surface A 434, 95-101 (2013).
44. Hui, P. C. et al. Preparation and characterisation of chitosan microcapsules loaded with Cortex Moutan. Int J Biol Macromol 55, 32-38 (2013).
45. Vihola, H., Laukkanen, A., Valtola, L., Tenhu, H. & Hirvonen, J. Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam). Biomaterials 26, 3055-3064 (2005).
46. Weyermann, J., Lochmann, D. & Zimmer, A. A practical note on the use of cytotoxicity assays. Int J Pharm 288, 369-376 (2005).
47. Papageorgiou, I. et al. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials 28, 2946-2958 (2007).
48. Kandárová, H., Hayden, P., Klausner, M., Kubilus, J. & Sheasgreen, J. An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model. J Vis Exp 29, 1366 (2009).
49. Spielmann, H. et al. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. ATLA 35, 559 (2007).
50. Geback, T., Marucci, M., Boissier, C., Arnehed, J. & Heintz, A. Investigation of the Effect of the Tortuous Pore Structure on Water Diffusion through a Polymer Film Using Lattice Boltzmann Simulations. J Phys Chem B 119, 5220-5227 (2015).
51. Kweon, O., Son, J., Kim, S., Chung, S. & Park, S. Antimicrobial and antioxidative activities from Moutan cortex extract, Kor J Postharvest Sci Technol. 5, 281-285 (1998).
52. Borges, A., Ferreira, C., Saavedra, M. J. & Simões, M. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria, Microbial Drug Resistance, 19, 256-265 (2013).
53. Liu, K. Y. et al. Anti-inflammatory and anti-allergic activities of Pentaherb formula, Moutan Cortex (Danpi) and gallic acid, Molecules, 18, 2483-2500 (2013).
54. Schmolka, I. R. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 6, 571-582 (1972).